|
LOC550112 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.723800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.714200E-01 |
| Normal-vs-Stage2 |
7.361200E-01 |
| Normal-vs-Stage3 |
3.934500E-02 |
| Normal-vs-Stage4 |
3.008000E-01 |
| Stage1-vs-Stage2 |
8.076600E-01 |
| Stage1-vs-Stage3 |
1.600010E-04 |
| Stage1-vs-Stage4 |
3.701900E-02 |
| Stage2-vs-Stage3 |
3.773700E-02 |
| Stage2-vs-Stage4 |
2.046800E-01 |
| Stage3-vs-Stage4 |
4.811200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.084000E-01 |
| Normal-vs-AfricanAmerican |
8.552200E-01 |
| Normal-vs-Asian |
4.805000E-01 |
| Caucasian-vs-AfricanAmerican |
5.747400E-01 |
| Caucasian-vs-Asian |
5.543200E-01 |
| AfricanAmerican-vs-Asian |
4.254400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.654200E-01 |
| Normal-vs-Female |
8.190200E-01 |
| Male-vs-Female |
9.174600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.065200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.448400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.584400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.601000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.935800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.440400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.229000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.665220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.257600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.298000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.182000E-02 |
| Normal-vs-Grade 2 |
9.886800E-01 |
| Normal-vs-Grade 3 |
7.307000E-01 |
| Normal-vs-Grade 4 |
1.644610E-01 |
| Grade 1-vs-Grade 2 |
3.724300E-02 |
| Grade 1-vs-Grade 3 |
3.324300E-02 |
| Grade 1-vs-Grade 4 |
1.224040E-02 |
| Grade 2-vs-Grade 3 |
6.280600E-01 |
| Grade 2-vs-Grade 4 |
7.349600E-02 |
| Grade 3-vs-Grade 4 |
1.730960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.837400E-01 |
| Normal-vs-ccB subtype |
5.502800E-01 |
| ccA subtype-vs-ccB subtype |
1.219220E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.885600E-01 |
| Normal-vs-N1 |
1.245770E-01 |
| N0-vs-N1 |
1.133030E-01 |
|
|
